Aktie 6598 APPLIED BIOCODE CORPORATION
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Applied BioCode Corporation

Aktien

6598

KYG0488D1051

6598

Schlusskurs Taiwan S.E.
Andere Börsenplätze
 00:00:00 17.05.2024 		% 5 Tage % 1. Jan.
21.05 TWD +5.78% Intraday Chart für Applied BioCode Corporation +5.25% -16.80%
15.04. Applied BioCode kündigt die Markteinführung des STI + Resistance Panel Assay nur für Forschungszwecke an CI
21.03. Applied BioCode kündigt Wechsel des CEO an CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Applied BioCode Announces the Launch of the STI + Resistance Panel Assay for Research Use Only
Applied BioCode Announces the Launch of the STI + Resistance Panel Assay for Research Use Only
Applied BioCode Announces Retirement of CEO Chris Bernard
Applied BioCode Announces CEO Changes
Applied BioCode Corporation Reports Earnings Results for the Full Year Ended December 31, 2023
Applied BioCode Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Applied BioCode Appoints Industry Veteran Beth Laderman as Chief Scientific Officer
Applied BioCode Appoints Beth Laderman as Chief Scientific Officer
Applied BioCode Corporation Announces the Resignation of Michael Sean Aye as Research and Development Officer
Applied BioCode Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Applied BioCode Corporation Announces the Change of Representative of Institutional Director
Applied BioCode Announces the Launch of the Fungal Panel Assay for Research Use
Applied Biocode Corporation Announces the Launch of the Fungal Panel Assay for Research Use
Applied BioCode Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023
Applied BioCode Announces Distribution Agreement with Medline Industries
Applied BioCode Corporation Announces Distribution Agreement with Medline Industries
Applied BioCode Corporation Reports Earnings Results for the Full Year Ended December 31, 2022
Applied BioCode Corporation Reports Earnings Results for the Full Year Ended December 31, 2022
Applied BioCode Corporation Appoints Liang-Kai Huang as Corporate Governance Officer
Applied BioCode Announces 2022 Q4 and Full year Revenue
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. 6598 Aktie
  4. Nachrichten Applied BioCode Corporation
  5. Andere Sprachen